Efficacy and safety of neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in locally advanced resectable esophageal squamous cell carcinoma.

J Cancer Res Clin Oncol · 2026 · PMC12982800 · PMID 41820752

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the NCRT group, lower TRG grades showed a consistent direction of association with better DFS, although this trend did not reach statistical significance; in contrast, no such trend was observed for OS (Fig. 3 g, h).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.